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Aplastic anemia (AA) is defined as a periph-eral blood pancytopenia with a hypocellular bone marrow. AA is considered an autoim-
mune disease with active destruction of blood-forming 
cells by lymphocytes. Most cases of the disease can be 
pathophysiologically characterized as T-cell-mediated 
organ-specific destruction of bone marrow hemato-
poeitic cells, with a strong association between AA and 
antigen HLA–DR2.1 The etiology in secondary  AA is 
represented by exposure to radiation, drugs and chemi-
cals, viruses (Epstein Barr, hepatitis virus, parvovirus, 
human immunodeficiency virus), immune diseases 
(eosinophilic fasciitis, thymoma), paroxysmal noctur-
nal hemoglobinuria (PNH) and the rest of cases are 
idiopathic  AA. The pathophysiologic pathways lead-
ing to  AA are damage to DNA inducing apoptosis by 
cytotoxic chemotherapy, irradiation, chemical or physi-
cal agents; marrow failure caused by medical drugs 
(chloramphenicol, antiepileptics, gold salts, antithyroid 
drugs), complex immune reactions leading to bone 
marrow failure induced by viruses. The pathogenic 
mechanism of idiopathic  AA is still unknown.2 The 
clinical picture includes an anemia-related syndrome, 
fever and hemorrhage. In tropical areas the differen-
tial diagnosis should include infectious disease, such as 
bacterial sepsis, leptospirosis, viral hemorrhagic fevers 
and visceral leishmaniasis.  AA is a rare complication 
of dengue hemorrhagic fever, and its pathophysiology is 
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Dengue fever has rarely been reported as an etiology for aplastic anemia. an 8-year-old girl was ad-
mitted with fever, myalgia and petechiae. Dengue virus igm antibodies were positive. she recovered 
completely, but her thrombocytopenia persisted. six weeks later she became pancytopenic. a bone 
marrow aspirate and biopsy showed severe aplastic anemia. she was treated with antithymocytic im-
munoglobulin, methylprednisolone and cyclosporine. she became transfusion independent 6 months 
later. Dengue-virus induced aplastic anemia is a rare entity, but it must be identified early for better 
outcome. immunosuppressive therapy can induce remission.
still poorly understood.3 We report a rare case of  AA 
induced by dengue virus infection.
CaSE
An 8-year-old girl presented with complaints of fever, 
myalgia and petechiae. She had no history of drug abuse 
and contact with possible toxic agents. Laboratory tests 
at admission showed a hemoglobin of 12.5 g/dL with a 
hematocrit of 0.37; a white cell count of 4×109/L (lym-
phocyte 74% and polymorphs were 23%), platelets were 
19×109/L (normal, 150-450). The hemoglobin showed 
a rising trend and reached a maximum of 15 g/dL with a 
hematocrit of 0.46. Dengue serology (Panbio, Brisbane, 
Australia) for IgM and IgG was positive at day 7 of ill-
ness. She was managed with fluid therapy and platelet 
transfusion. She recovered from fever and stayed well 
for 2 weeks, but her thrombocytopenia persisted. She 
started to have fever again 4 weeks later. Investigations 
showed pancytopenia (Hb 4.1 g/dL, total lymphocyte 
count with absolute neutrophil count of 0.25×109/L, 
absolute lymphocyte count of 1.9×109/L, platelets were 
11×109/L and reteculocyte count of 0.1%). There was 
no family history of similar complaints. On physical 
examination she was pale without lymphadenopathy or 
organomegaly. A repeated complete blood count showed 
persistent pancytopenia and hypoplastic anemia was 
considered. Bone marrow aspiration showed severe hy-
pocellularity, an increased number of fat cells, residual 
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lymphocytosis, plasma cells, and stromal elements. Bone 
marrow biopsy revealed a cellularity of 5% to 10% which 
confirmed the diagnosis of severe  AA. Vitamin B12 and 
folic acid levels were normal. Serology for viral hepati-
tis A, B, C, HIV and cytomegalovirus were negative. 
Flow cytometry (CD55 and CD59) and chromosome 
breakage studies were negative for paroxysmal nocturnal 
hemoglobinuria (PNH) and Fanconi anemia. A pos-
sible diagnosis of dengue virus-induced  AA was made. 
The child received packed cell and platelet transfusions 
multiple times . No spontaneous marrow recovery hap-
pened until 3 months and she was treated with rabbit 
antithymocyte immunoglobulin (Thymoglobulin) 3.75 
mg/kg IV daily for 5 days followed by oral cyclosporine 
10 mg/kg, later dose adjusted to a target trough level of 
150-200 ng/mL. She became platelet and packed cell 
transfusion independent 2 months and 6 months later 
respectively (Figure 1).
DISCuSSIOn
Only a few cases are reported of  AA due to dengue fe-
ver.4,5 Albuquerque et al4 and Pallota et al5 have described 
similar cases from Latin America. In our case dengue 
was confirmed by serology, which was positive for both 
IgG and IgM antibodies. The patient was admitted 
with hemorrhagic manifestations and had recovery, but 
thrombocytopenia persisted and she later developed 
pancytopenia. Other possible causes like megaloblas-
tic anemia and myelodysplasia were excluded on bone 
marrow examination. PNH workup was negative. After 
exclusion of other possible etiologies for  AA, the final 
diagnosis was dengue virus-induced  AA in our case. 
Dengue fever virus is endemic and causes hemorrhag-
ic fever in India. In year 2010 , a total of 27 196 cases and 
104 deaths were reported in India. Delhi had the high-
est, 6240 cases with 8 deaths.6 Dengue virus and other 
arboviruses can be associated with bone marrow failure. 
It is known that dengue subtype DEN-4 can reproduce 
in progenitor cells from the bone marrow.7 Neutropenia 
and thrombocytopenia are common in dengue infection, 
and the bone marrow is markedly hypocellular with ab-
normal megakaryopoesis.8 The seventh day after viral 
infection an abnormal vacuolization of lymphocytes 
appears. Reticulocutopenia, lymphocytopenia, throm-
bocytopenia and granulocytopenia appear in this order.9 
The patient described above had systemic symptoms, an 
increase in hematocrit, thrombocytopenia, and hemor-
rhagic manifestation of abnormalities of capillary per-
meability, which characterize dengue hemorrhagic fever 
(DHF). DHF usually appears during the second epi-
sode of dengue infection in 95% of cases.3 Our patient 
had no such previous history of dengue. 
The association between viral infection and different 
forms of bone marrow failure can be caused by viral-
induced inhibition of multiplication of hematopoietic 
cells. In the acute phase of infection and viremia, viral 
replication in the bone marrow leads to pancytopenia.10 
The pathophysiology of dengue-induced  AA is poorly 
understood. It is believed that cellular destruction is a 
direct consequence of both peripheral destruction in-
duced by immune complexes and direct viral injury to 
born marrow.3 
HLA-compatible stem cell donor is treatment of 
choice in  AA. Unfortunately our patient did not have 
any matched sibling donor so antithymocyte immuno-
globulin (ATG) was offered as alternative therapy. As 
seen in previous cases4,5 our patient also responded to 
ATG and cyclosporine. In summary, dengue virus infec-
tion can induce  AA. Though it is a rare complication 
it must be identified early specially in endemic areas. 
Immunosuppressive therapy can lead to complete re-
mission.
Figure 1. Weekly hemoglobin (Hb), absolute neutrophil count (anC) and platelet values 
from the onset of dengue fever and at onset of aplastic anemia and after therapy with 
anti-thymoglobulin (aTG). arrows show blood transfusion (BT) and platelet transfusion 
(plT).
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